… receptor antagonists in these disease processes, particularly hypertension, … aldosterone in
their pathogenesis. We review the role of aldosterone in these various cardiovascular disease …

… aldosterone/MR dysregulation. This review clearly documented an expanding role for
aldosterone/MR’s dysregulation in CV diseases … aldosterone/MR’s potential roles in these …

… roles makes tissue RAAS attractive therapeutic targets in diverse disease states. The present
review aims to put forth the involvement of RAAS in diabetes and cardiovascular diseases. …

… link aldosterone excess to other cardiovascular disease processes. In congestive heart
failure, higher plasma aldosterone … Cross-sectional studies implicate aldosterone excess as a …

… The only remaining question is how early in the heart failure disease process should we
initiate aldosterone blockade. Aldosterone blockade also reduces blood pressure in virtually all …

… aldosterone and (ii) aggravate aldosterone secretion in the setting of PA. Importantly,
Rossi GP et al. drew attention to the aldosterone–… type 1 PTH receptor in the aldosterone-producing …

… The role of mineralocorticoids in the development of cardiovascular disease (CVD), … ,
chronic kidney disease (CKD), and hypertension is a growing field of interest. Aldosterone, mainly …

… data on an association between aldosterone and cardiovascular disease; to the best of our
… between aldosterone levels and cardiovascular outcomes. When aldosterone levels are …

… aldosterone by adrenalectomy. In the present manuscript, we review some of the most recent
discoveries in the field of aldosterone … of this mineralocorticoid in cardiovascular tissues. …

… The purpose of this brief review is to highlight a number of discoveries during the past
year that have either reinforced or extended concepts of the nonclassical actions of …